SGLT2 Inhibitors and Kidney Protection: Mechanisms Beyond Tubuloglomerular Feedback

Area of Science:

• Nephrology
• Pharmacology

Background:

• Sodium-glucose cotransporter 2 (SGLT2) inhibitors are crucial in managing chronic kidney disease (CKD).
• Current understanding emphasizes tubuloglomerular feedback activation as the primary kidney protection mechanism.
• Emerging evidence questions the sole reliance on this mechanism, prompting further investigation.

Purpose of the Study:

• To review the role of SGLT2 inhibitors in tubuloglomerular feedback.
• To summarize emerging evidence on alternative mechanisms of kidney protection by SGLT2 inhibitors.
• To deepen the understanding of SGLT2 inhibition's physiological effects on kidney health.

Main Methods:

• Literature review of experimental studies on SGLT2 inhibitors.
• Analysis of data concerning tubuloglomerular feedback activation.
• Synthesis of evidence on other proposed mechanisms of kidney protection.

Main Results:

• SGLT2 inhibitors' role in tubuloglomerular feedback is examined.
• Evidence is presented on other potential mechanisms including energy substrate optimization, autophagy regulation, sympathetic hyperactivity attenuation, and improved vascular function.
• The primacy of tubuloglomerular feedback as the sole mechanism is questioned.

Conclusions:

• SGLT2 inhibitors offer kidney protection through multiple pathways beyond tubuloglomerular feedback.
• Further research into these diverse physiological effects is essential for a comprehensive understanding.
• This knowledge will refine therapeutic strategies for CKD management.